News & Articles

FEATURED ARTICLE

Neoantigen-Based Next-Gen Immunotherapy

Neoantigen-based immunotherapy is revolutionizing cancer treatment by focusing on neoantigens—unique proteins formed by mutations in cancer cells. These neoantigens are distinct from normal...

August 20, 2024

Browse articles by topic:

Potential Immunotherapy Target TM4SF1

September 5, 2022

5 min read

TM4SF1 (Transmembrane 4L six family member 1) is a member of the TM4SF subfamily in the Tetraspanin superfamily. It was...